Neev Biochem Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 3.01 Cr
as on 16-11-2024
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 28.61 Cr
as on 16-11-2024
- Satisfied Charges ₹ 17.00 Cr
as on 16-11-2024
- Revenue 177.95%
(FY 2023)
- Profit 83.33%
(FY 2023)
- Ebitda 580.73%
(FY 2023)
- Net Worth -79.12%
(FY 2023)
- Total Assets 10.00%
(FY 2023)
About Neev Biochem
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.01 Cr.
The company currently has active open charges totaling ₹28.61 Cr. The company has closed loans amounting to ₹17.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Annuja Dhaddha, Prayank Dhaddha, Akash Parakh, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999PN2018PTC176759
- Company No.
176759
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 May 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Neev Biochem?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Annuja Dhaddha  | Director | 22-May-2018 | Current |
| Prayank Dhaddha | Director | 19-Jun-2023 | Current |
| Akash Parakh | Director | 26-Nov-2018 | Current |
| Vinayak Takale | Director | 12-Nov-2022 | Current |
Financial Performance and Corporate Structure Insights of Neev Biochem.
Neev Biochem Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 177.95% increase. The company also saw a substantial improvement in profitability, with a 83.33% increase in profit. The company's net worth observed a substantial decline by a decrease of 79.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neev Biochem?
In 2023, Neev Biochem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Zenith Algorithms Private LimitedActive 5 years 6 months
Annuja Dhaddha and Prayank Dhaddha are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 29 Oct 2020 | ₹26.50 Cr | Open |
Hdfc Bank Limited Creation Date: 27 Oct 2020 | ₹2.11 Cr | Open |
Others Creation Date: 22 Jul 2019 | ₹17.00 Cr | Satisfied |
How Many Employees Work at Neev Biochem?
Neev Biochem has a workforce of 31 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neev Biochem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neev Biochem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
